SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-22-062330
Filing Date
2022-12-21
Accepted
2022-12-21 16:14:59
Documents
2
Period of Report
2022-12-12

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2963
2 POA DOCUMENT poa.txt EX-24 3600
  Complete submission text file 0001209191-22-062330.txt   7963
Mailing Address 4800 HAMPDEN LANE SUITE 200 BETHESDA MD 20814
Business Address 4800 HAMPDEN LANE SUITE 200 BETHESDA MD 20814 (301) 500-1556
Gain Therapeutics, Inc. (Issuer) CIK: 0001819411 (see all company filings)

IRS No.: 851726310 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O GAIN THERAPEUTICS, INC. 4800 MONTGOMERY LANE, SUITE 220 BETHESDA MD 20814
Business Address
Fuggetta Gianluca (Reporting) CIK: 0001958188 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40237 | Film No.: 221478612